Smit K.N., Jager M.J., De Klein A., Kiliҫ E. 2020. Uveal melanoma: Towards a molecular understanding. Prog. Retin. Eye Res. 75, 100800.

Article  PubMed  Google Scholar 

Shields C.L., Manalac J., Das C., Ferguson K., Shields J.A. 2014. Choroidal melanoma: Clinical features, classification, and top 10 pseudomelanomas. Curr. Opin. Ophthalmol. 25 (3), 177–185.

Article  PubMed  Google Scholar 

Singh A.D., Turell M.E., Topham A.K. 2011. Uveal melanoma: Trends in incidence, treatment, and survival. Ophthalmology. 118 (9), 1881–1885.

Article  PubMed  Google Scholar 

Lin J.Y., Fisher D.E. 2007. Melanocyte biology and skin pigmentation. Nature. 445 (7130), 843–850.

Article  CAS  PubMed  Google Scholar 

Bertrand J., Steingrimsson E., Jouenne F., Paillerets B., Larue L. 2020. Melanoma risk and melanocyte biology. Acta Derm. Venereol. 100 (11), 272–283.

Article  Google Scholar 

D’Alba L., Shawkey M.D. 2019. Melanosomes: Biogenesis, properties, and evolution of an ancient organelle. Physiol. Rev. 99 (1), 1–19.

Article  PubMed  Google Scholar 

Upadhyay P.R., Ho T., Abdel-Malek Z.A. 2021. Participation of keratinocyte- and fibroblast-derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders. Pigment. Cell Melanoma Res. 34 (4), 762–776.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohbayashi N., Fukuda M. 2020. Recent advances in understanding the molecular basis of melanogenesis in melanocytes. F1000Res. 9, 608.

Article  CAS  Google Scholar 

Solano F. 2020. Photoprotection and skin pigmentation: Melanin-related molecules and some other new agents obtained from natural sources. Molecules. 25 (7), 1537.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li M., Knapp S.K., Iden S. 2020. Mechanisms of melanocyte polarity and differentiation: What can we learn from other neuroectoderm-derived lineages? Curr. Opin. Cell Biol. 67, 99–108.

Article  CAS  PubMed  Google Scholar 

Van Der Kooij M.K., Speetjens F.M., Van Der Burg S.H., Kapiteijn E. 2019. Uveal versus cutaneous melanoma; same origin, very distinct tumor types. Cancers. 11 (6), 845.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Raamsdonk C.D., Griewank K.G., Crosby M.B., Garrido M.C., Vemula S., Wiesner T., Obenauf A.C., Wackernagel W., Green G., Bouvier N., Sozen M.M., Baimukanova G., Roy R., Heguy A., Dolgalev I., Kh-anin R., Busam K., Speicher M.R., O’Brien J., Bastian B.C. 2010. Mutations in GNA11 in uveal melanoma. N. Engl. J. Med. 363 (23), 2191–2199.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robertson A.G., Shih J., Yau C., Gibb E.A., Oba J., Mungall K.L., Hess J.M., Uzunangelov V., Walter V., Danilova L., Lichtenberg T.M., Kucherlapati M., Kimes P.K., Tang M., Penson A., Babur O., Akbani R., Bristow C.A., Hoadley K.A., Iype L., Chang M.T., Cherniack A.D., Benz C., Mills G.B., Ver-haak R.G.W., Griewank K.G., Felau I., Zenklu-sen J.C., Gershenwald J.E., Schoenfield L., Lazar A.J., Abdel-Rahman M.H., Roman-Roman S., Stern M.-H., Cebulla C.M., Williams M.D., Jager M.J., Coupland S.E., Esmaeli B., Kandoth C., Woodman S.E., 2017. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell. 32 (2), 204‒220.e15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore A.R., Ceraudo E., Sher J.J., Guan Y., Shoushtari A.N., Chang M.T., Zhang J.Q., Walczak E.G., Kazmi M.A., Taylor B.S., Huber T., Chi P., Sakmar T.P., Chen Y. 2016. Recurrent activat-ing mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma. Nat. Genet. 48 (6), 675–680.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park J.J., Diefenbach R.J., Joshua A.M., Kefford R.F., Carlino M.S., Rizos H. 2018. Oncogenic signaling in uveal melanoma. Pigment. Cell Melanoma Res. 31 (6), 661–672.

Article  PubMed  Google Scholar 

Harbour J.W., Onken M.D., Roberson E.D.O., Duan S., Cao L., Worley L.A., Council M.L., Matatall K.A., Helms C., Bowcock A.M. 2010. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 330 (6009), 1410–1413.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng X., Arang N., Rigiracciolo D.C., Lee J.S., Yeerna H., Wang Z., Lubrano S., Kishore A., Pachter J.A., König G.M., Maggiolini M., Kostenis E., Schlaepfer D.D., Tamayo P., Chen Q., Ruppin E., Gutkind J.S. 2019. A platform of synthetic lethal gene interaction networks reveals that the GNAQ uveal melanoma oncogene controls the hippo pathway through FAK. Cancer Cell. 35 (3), 457–472.e5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paradis J.S., Acosta M., Saddawi-Konefka R., Kishore A., Lubrano S., Gomes F., Arang N., Tiago M., Coma S., Wu X., Ford K., Day C.-P., Merlino G., Mali P., Pachter J.A., Sato T., Aplin A.E., Gutkind J.S. 2021. Synthetic lethal screens reveal cotargeting FAK and MEK as a multimodal precision therapy for GNAQ-driven uveal melanoma. Clin. Cancer Res. 27 (11), 3190–3200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma J., Weng L., Bastian B.C., Chen X. 2021. Functional characterization of uveal melanoma oncogenes. Oncogene. 40 (4), 806–820.

Article  CAS  PubMed  Google Scholar 

Louie B.H., Kurzrock R. 2020. BAP1: Not just a BRCA1-associated protein. Cancer Treat Rev. 90, 102091.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landreville S., Agapova O.A., Matatall K.A., Kneass Z.T., Onken M.D., Lee R.S., Bowcock A.M., Harbour J.W. 2012. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin. Cancer Res. 18 (2), 408–416.

Article  CAS  PubMed  Google Scholar 

Furney S.J., Pedersen M., Gentien D., Dumont A.G., Rapinat A., Desjardins L., Turajlic S., Piperno-Neumann S., De La Grange P., Roman-Roman S., Stern M.-H., Marais R. 2013. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discovery. 3 (10), 1122–1129.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Souto E.B., Zielinska A., Luis M., Carbone C., Martins-Gomes C., Souto S.B., Silva A.M. 2019. Uveal melanoma: Physiopathology and new in situ-specific therapies. Cancer Chemother. Pharmacol. 84 (1), 15–32.

Article  CAS  PubMed  Google Scholar 

Seedor R.S., Eschelman D.J., Gonsalves C.F., Adamo R.D., Orloff M., Amjad A., Sharpe-Mills E., Chervoneva I., Shields C.L., Shields J.A., Mastrangelo M.J., Sato T. 2020. An outcome assessment of a single institution’s longitudinal experience with uveal melanoma patients with liver metastasis. Cancers. 12 (1), 117.

Article  PubMed  PubMed Central  Google Scholar 

Jager M.J., Shields C.L., Cebulla C.M., Abdel-Rahman M.H., Grossniklaus H.E., Stern M.-H., Carvajal R.D., Belfort R.N., Jia R., Shields J.A., Damato B.E. 2020. Uveal melanoma. Nat. Rev. Dis. Primers. 6 (1), 24.

Article  PubMed  Google Scholar 

Zhang F., Deng Y., Wang D., Wang S. 2022. Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma. Sci. Rep. 12 (1), 1640.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang X., Hu F., Liu J.A., Yu S., Cheung M.P.L., Liu X., Ng I.O.-L., Guan X.-Y., Wong K.K.W., Sharma R., Lung H.L., Jiao Y., Lee L.T.O., Cheung M. 2020. Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma. Oncogene. 39 (20), 4061–4076.

Seitz T., John N., Sommer J., Dietrich P., Thasler W.E., Hartmann A., Evert K., Lang S.A., Bosserhoff A., Hellerbrand C. 2022. Role of fibroblast growth factors in the crosstalk of hepatic stellate cells and uveal melanoma cells in the liver metastatic niche. Int. J. Mol. Sci. 23 (19), 11524.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trocmé E., Mougiakakos D., Johansson C.C., All-Eriksson C., Economou M.A., Larsson O., Seregard S., Kiessling R., Lin Y. 2012. Nuclear HER3 is associated with favorable overall survival in uveal melanoma. Int. J. Cancer. 130 (5), 1120–1127.

Article  PubMed  Google Scholar 

Amaro A., Mirisola V., Angelini G., Musso A., Tosetti F., Esposito A.I., Perri P., Lanza F., Nasciuti F., Mosci C., Puzone R., Salvi S., Truini M., Poggi A., Pfeffer U. 2013. Evidence of epidermal growth factor receptor expression in uveal melanoma: Inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity. Eur. J. Cancer. 49 (15), 3353–3365.

Article  CAS  PubMed  Google Scholar 

Lai K., Sharma V., Jager M.J., Conway R.M., Madigan M.C. 2007. Expression and distribution of MUC18 in human uveal melanoma. Virchows Arch. 451 (5), 967–976.

Article  CAS  PubMed  Google Scholar 

Wang Z., Xu Q., Zhang N., Du X., Xu G., Yan X. 2020. CD146, from a melanoma cell adhesion molecule to a signaling receptor. Sig. Transduct. Target Ther. 5 (1), 148.

Article  CAS  Google Scholar 

Zhang R., Chen X., Chen S., Tang J., Chen F., Lin Y., Reinach P.S., Yan X., Tu L., Duan H., Qu J., Hou Q. 2022. Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry. Cell Oncol. 45 (4), 557–572.

Article  CAS  Google Scholar 

Piquet L., Coutant K., Mitchell A., Ben Anes A., Bollmann E., Schoonjans N., Bérubé J., Bordelea F., Brisson A., Landreville S. 2022. Extracellular vesicles from ocular melanoma have pro-fibrotic and pro-angiogenic properties on the tumor microenvironment. Cells. 11 (23), 3828.

Article  CAS  PubMed